nodes	percent_of_prediction	percent_of_DWPC	metapath
Etidronic acid—PTPRS—ECM proteoglycans—LUM—melanoma	0.0422	0.0806	CbGpPWpGaD
Etidronic acid—ATP6V1A—hair follicle—melanoma	0.031	0.241	CbGeAlD
Etidronic acid—PTPRS—ECM proteoglycans—VCAN—melanoma	0.029	0.0554	CbGpPWpGaD
Etidronic acid—PTPRS—ECM proteoglycans—TNC—melanoma	0.0262	0.05	CbGpPWpGaD
Etidronic acid—PTPRS—ECM proteoglycans—SPARC—melanoma	0.0253	0.0483	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—CEACAM1—melanoma	0.0229	0.0437	CbGpPWpGaD
Etidronic acid—PTPRS—ECM proteoglycans—ITGAV—melanoma	0.0198	0.0379	CbGpPWpGaD
Etidronic acid—PTPRS—ECM proteoglycans—ITGB1—melanoma	0.018	0.0344	CbGpPWpGaD
Etidronic acid—PTPRS—ECM proteoglycans—ITGB3—melanoma	0.0156	0.0298	CbGpPWpGaD
Etidronic acid—ATP6V1A—eye—melanoma	0.0155	0.121	CbGeAlD
Etidronic acid—ATP6V1A—retina—melanoma	0.0154	0.119	CbGeAlD
Etidronic acid—PTPRS—head—melanoma	0.0153	0.119	CbGeAlD
Etidronic acid—PTPRS—Extracellular matrix organization—CAPN1—melanoma	0.0139	0.0265	CbGpPWpGaD
Etidronic acid—ATP6V1A—skin of body—melanoma	0.0135	0.105	CbGeAlD
Etidronic acid—ATP6V1A—mammalian vulva—melanoma	0.0123	0.0956	CbGeAlD
Etidronic acid—PTPRS—Extracellular matrix organization—LUM—melanoma	0.012	0.023	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—BSG—melanoma	0.0112	0.0214	CbGpPWpGaD
Etidronic acid—PTPRS—lymph node—melanoma	0.0107	0.0831	CbGeAlD
Etidronic acid—Rash maculo-papular—Vemurafenib—melanoma	0.0104	0.0303	CcSEcCtD
Etidronic acid—PTPRS—Extracellular matrix organization—MMP8—melanoma	0.0102	0.0195	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—LOX—melanoma	0.00961	0.0184	CbGpPWpGaD
Etidronic acid—ATP6V1A—Latent infection of Homo sapiens with Mycobacterium tuberculosis—NOS2—melanoma	0.00906	0.0173	CbGpPWpGaD
Etidronic acid—ATP6V1A—head—melanoma	0.0088	0.0684	CbGeAlD
Etidronic acid—PTPRS—Extracellular matrix organization—COL2A1—melanoma	0.00877	0.0168	CbGpPWpGaD
Etidronic acid—Arthritis—Vemurafenib—melanoma	0.00851	0.0249	CcSEcCtD
Etidronic acid—PTPRS—Extracellular matrix organization—VCAN—melanoma	0.00827	0.0158	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—ABCB5—melanoma	0.00759	0.0145	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—TNC—melanoma	0.00746	0.0142	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—SPARC—melanoma	0.0072	0.0138	CbGpPWpGaD
Etidronic acid—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.00632	0.0185	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Vemurafenib—melanoma	0.00625	0.0183	CcSEcCtD
Etidronic acid—ATP6V1A—lymph node—melanoma	0.00616	0.0479	CbGeAlD
Etidronic acid—PTPRS—Extracellular matrix organization—ITGA4—melanoma	0.00612	0.0117	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—CD44—melanoma	0.00612	0.0117	CbGpPWpGaD
Etidronic acid—Oesophagitis—Dactinomycin—melanoma	0.00588	0.0172	CcSEcCtD
Etidronic acid—PTPRS—Extracellular matrix organization—ITGAV—melanoma	0.00565	0.0108	CbGpPWpGaD
Etidronic acid—Erythema multiforme—Vemurafenib—melanoma	0.00541	0.0158	CcSEcCtD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—ARL2—melanoma	0.00526	0.01	CbGpPWpGaD
Etidronic acid—Arthritis—Bleomycin—melanoma	0.00515	0.0151	CcSEcCtD
Etidronic acid—PTPRS—Extracellular matrix organization—ITGB1—melanoma	0.00513	0.00981	CbGpPWpGaD
Etidronic acid—Alopecia—Vemurafenib—melanoma	0.00506	0.0148	CcSEcCtD
Etidronic acid—Erythema—Vemurafenib—melanoma	0.00498	0.0146	CcSEcCtD
Etidronic acid—Amnesia—Carmustine—melanoma	0.00465	0.0136	CcSEcCtD
Etidronic acid—Amnesia—Temozolomide—melanoma	0.0045	0.0132	CcSEcCtD
Etidronic acid—PTPRS—Extracellular matrix organization—PRKCA—melanoma	0.00445	0.0085	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—ITGB3—melanoma	0.00445	0.0085	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—FGF1—melanoma	0.00438	0.00836	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—SPP1—melanoma	0.00436	0.00834	CbGpPWpGaD
Etidronic acid—Arthralgia—Vemurafenib—melanoma	0.00424	0.0124	CcSEcCtD
Etidronic acid—Pancytopenia—Bleomycin—melanoma	0.00411	0.012	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—MAP2K2—melanoma	0.0041	0.00784	CbGpPWpGaD
Etidronic acid—Bone pain—Docetaxel—melanoma	0.00404	0.0118	CcSEcCtD
Etidronic acid—Infection—Vemurafenib—melanoma	0.00404	0.0118	CcSEcCtD
Etidronic acid—PTPRS—Extracellular matrix organization—MMP1—melanoma	0.00399	0.00763	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—SLC15A2—melanoma	0.00398	0.00761	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—SLC17A5—melanoma	0.00384	0.00733	CbGpPWpGaD
Etidronic acid—Pancytopenia—Dactinomycin—melanoma	0.00384	0.0112	CcSEcCtD
Etidronic acid—PTPRS—Extracellular matrix organization—KDR—melanoma	0.00378	0.00723	CbGpPWpGaD
Etidronic acid—Musculoskeletal discomfort—Vemurafenib—melanoma	0.0037	0.0108	CcSEcCtD
Etidronic acid—PTPRS—Extracellular matrix organization—FN1—melanoma	0.00364	0.00696	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—ICAM1—melanoma	0.00363	0.00693	CbGpPWpGaD
Etidronic acid—Pancytopenia—Carmustine—melanoma	0.00359	0.0105	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.00357	0.0105	CcSEcCtD
Etidronic acid—Oesophagitis—Docetaxel—melanoma	0.00354	0.0104	CcSEcCtD
Etidronic acid—Risedronate—PTGS2—melanoma	0.00351	0.529	CrCbGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—SLC6A11—melanoma	0.00348	0.00666	CbGpPWpGaD
Etidronic acid—Constipation—Vemurafenib—melanoma	0.00348	0.0102	CcSEcCtD
Etidronic acid—Pancytopenia—Temozolomide—melanoma	0.00347	0.0102	CcSEcCtD
Etidronic acid—Agranulocytosis—Dactinomycin—melanoma	0.00336	0.00984	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Carmustine—melanoma	0.0033	0.00967	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00323	0.00945	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—MYO7A—melanoma	0.00322	0.00614	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—CDH1—melanoma	0.00321	0.00613	CbGpPWpGaD
Etidronic acid—Neuropathy peripheral—Temozolomide—melanoma	0.00319	0.00935	CcSEcCtD
Etidronic acid—Clodronate—PTGS2—melanoma	0.00312	0.471	CrCbGaD
Etidronic acid—PTPRS—Extracellular matrix organization—MMP2—melanoma	0.00309	0.0059	CbGpPWpGaD
Etidronic acid—Alopecia—Bleomycin—melanoma	0.00306	0.00897	CcSEcCtD
Etidronic acid—Erythema multiforme—Dactinomycin—melanoma	0.00306	0.00895	CcSEcCtD
Etidronic acid—Erythema—Bleomycin—melanoma	0.00302	0.00883	CcSEcCtD
Etidronic acid—Hallucination—Carmustine—melanoma	0.00301	0.00881	CcSEcCtD
Etidronic acid—Hypersensitivity—Vemurafenib—melanoma	0.00299	0.00877	CcSEcCtD
Etidronic acid—PTPRS—Extracellular matrix organization—FGF2—melanoma	0.00293	0.00561	CbGpPWpGaD
Etidronic acid—Hallucination—Temozolomide—melanoma	0.00291	0.00852	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—MAP2K1—melanoma	0.00291	0.00556	CbGpPWpGaD
Etidronic acid—Pruritus—Vemurafenib—melanoma	0.00288	0.00842	CcSEcCtD
Etidronic acid—Alopecia—Dactinomycin—melanoma	0.00286	0.00836	CcSEcCtD
Etidronic acid—Erythema—Dactinomycin—melanoma	0.00281	0.00824	CcSEcCtD
Etidronic acid—Anaemia—Bleomycin—melanoma	0.00279	0.00817	CcSEcCtD
Etidronic acid—Diarrhoea—Vemurafenib—melanoma	0.00278	0.00814	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—FGF2—melanoma	0.00277	0.00529	CbGpPWpGaD
Etidronic acid—Erythema multiforme—Temozolomide—melanoma	0.00276	0.00809	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—HS3ST5—melanoma	0.00273	0.00522	CbGpPWpGaD
Etidronic acid—Leukopenia—Bleomycin—melanoma	0.0027	0.00791	CcSEcCtD
Etidronic acid—Alopecia—Carmustine—melanoma	0.00267	0.00783	CcSEcCtD
Etidronic acid—Erythema—Carmustine—melanoma	0.00263	0.00771	CcSEcCtD
Etidronic acid—Anaemia—Dactinomycin—melanoma	0.0026	0.00762	CcSEcCtD
Etidronic acid—Vomiting—Vemurafenib—melanoma	0.00258	0.00757	CcSEcCtD
Etidronic acid—Alopecia—Temozolomide—melanoma	0.00258	0.00756	CcSEcCtD
Etidronic acid—Rash—Vemurafenib—melanoma	0.00256	0.0075	CcSEcCtD
Etidronic acid—Dermatitis—Vemurafenib—melanoma	0.00256	0.0075	CcSEcCtD
Etidronic acid—Headache—Vemurafenib—melanoma	0.00255	0.00746	CcSEcCtD
Etidronic acid—Erythema—Temozolomide—melanoma	0.00254	0.00745	CcSEcCtD
Etidronic acid—Discomfort—Bleomycin—melanoma	0.00254	0.00743	CcSEcCtD
Etidronic acid—Leukopenia—Dactinomycin—melanoma	0.00252	0.00738	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—PIK3CB—melanoma	0.00252	0.00481	CbGpPWpGaD
Etidronic acid—Confusional state—Bleomycin—melanoma	0.00248	0.00727	CcSEcCtD
Etidronic acid—PTPRS—Extracellular matrix organization—CASP3—melanoma	0.00246	0.00469	CbGpPWpGaD
Etidronic acid—Infection—Bleomycin—melanoma	0.00245	0.00716	CcSEcCtD
Etidronic acid—Anaemia—Carmustine—melanoma	0.00243	0.00713	CcSEcCtD
Etidronic acid—Nausea—Vemurafenib—melanoma	0.00241	0.00707	CcSEcCtD
Etidronic acid—Discomfort—Dactinomycin—melanoma	0.00237	0.00693	CcSEcCtD
Etidronic acid—Leukopenia—Carmustine—melanoma	0.00236	0.0069	CcSEcCtD
Etidronic acid—Anaemia—Temozolomide—melanoma	0.00235	0.00689	CcSEcCtD
Etidronic acid—Angioedema—Temozolomide—melanoma	0.00233	0.00681	CcSEcCtD
Etidronic acid—PTPRS—Extracellular matrix organization—MMP9—melanoma	0.00232	0.00444	CbGpPWpGaD
Etidronic acid—Pancytopenia—Docetaxel—melanoma	0.00231	0.00675	CcSEcCtD
Etidronic acid—Infection—Dactinomycin—melanoma	0.00228	0.00668	CcSEcCtD
Etidronic acid—Leukopenia—Temozolomide—melanoma	0.00228	0.00667	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—MYO7A—melanoma	0.00225	0.0043	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—DRAP1—melanoma	0.00225	0.0043	CbGpPWpGaD
Etidronic acid—Musculoskeletal discomfort—Bleomycin—melanoma	0.00224	0.00657	CcSEcCtD
Etidronic acid—Paraesthesia—Bleomycin—melanoma	0.00221	0.00647	CcSEcCtD
Etidronic acid—Confusional state—Carmustine—melanoma	0.00217	0.00635	CcSEcCtD
Etidronic acid—Arthralgia—Temozolomide—melanoma	0.00217	0.00634	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Docetaxel—melanoma	0.00215	0.00629	CcSEcCtD
Etidronic acid—Discomfort—Temozolomide—melanoma	0.00214	0.00627	CcSEcCtD
Etidronic acid—Infection—Carmustine—melanoma	0.00214	0.00625	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Docetaxel—melanoma	0.00212	0.00622	CcSEcCtD
Etidronic acid—Confusional state—Temozolomide—melanoma	0.00209	0.00613	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00209	0.00613	CcSEcCtD
Etidronic acid—Infection—Temozolomide—melanoma	0.00206	0.00604	CcSEcCtD
Etidronic acid—Feeling abnormal—Bleomycin—melanoma	0.00203	0.00594	CcSEcCtD
Etidronic acid—Agranulocytosis—Docetaxel—melanoma	0.00202	0.00592	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Carmustine—melanoma	0.00196	0.00573	CcSEcCtD
Etidronic acid—Urticaria—Bleomycin—melanoma	0.00196	0.00573	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—TRRAP—melanoma	0.00195	0.00372	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CUL3—melanoma	0.00195	0.00372	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—NRAS—melanoma	0.00194	0.00371	CbGpPWpGaD
Etidronic acid—Paraesthesia—Carmustine—melanoma	0.00193	0.00565	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—TAS2R60—melanoma	0.00191	0.00366	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—AKR1B10—melanoma	0.00189	0.00362	CbGpPWpGaD
Etidronic acid—Feeling abnormal—Dactinomycin—melanoma	0.00189	0.00554	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Temozolomide—melanoma	0.00189	0.00554	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Dactinomycin—melanoma	0.00188	0.0055	CcSEcCtD
Etidronic acid—Paraesthesia—Temozolomide—melanoma	0.00187	0.00546	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—MAPK3—melanoma	0.00186	0.00355	CbGpPWpGaD
Etidronic acid—Erythema multiforme—Docetaxel—melanoma	0.00184	0.00538	CcSEcCtD
Etidronic acid—Constipation—Carmustine—melanoma	0.00184	0.00538	CcSEcCtD
Etidronic acid—Dyspepsia—Temozolomide—melanoma	0.00183	0.00535	CcSEcCtD
Etidronic acid—Abdominal pain—Dactinomycin—melanoma	0.00182	0.00532	CcSEcCtD
Etidronic acid—Hypersensitivity—Bleomycin—melanoma	0.00181	0.00531	CcSEcCtD
Etidronic acid—Constipation—Temozolomide—melanoma	0.00178	0.0052	CcSEcCtD
Etidronic acid—Feeling abnormal—Carmustine—melanoma	0.00177	0.00519	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—MAPK1—melanoma	0.00177	0.00338	CbGpPWpGaD
Etidronic acid—Gastrointestinal pain—Carmustine—melanoma	0.00176	0.00515	CcSEcCtD
Etidronic acid—Pruritus—Bleomycin—melanoma	0.00174	0.0051	CcSEcCtD
Etidronic acid—Alopecia—Docetaxel—melanoma	0.00172	0.00503	CcSEcCtD
Etidronic acid—Feeling abnormal—Temozolomide—melanoma	0.00171	0.00501	CcSEcCtD
Etidronic acid—Abdominal pain—Carmustine—melanoma	0.0017	0.00498	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Temozolomide—melanoma	0.0017	0.00497	CcSEcCtD
Etidronic acid—Erythema—Docetaxel—melanoma	0.00169	0.00496	CcSEcCtD
Etidronic acid—Hypersensitivity—Dactinomycin—melanoma	0.00169	0.00495	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—LUM—melanoma	0.00169	0.00323	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—KRAS—melanoma	0.00167	0.00319	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—HPSE—melanoma	0.00166	0.00317	CbGpPWpGaD
Etidronic acid—Urticaria—Temozolomide—melanoma	0.00165	0.00483	CcSEcCtD
Etidronic acid—Abdominal pain—Temozolomide—melanoma	0.00164	0.00481	CcSEcCtD
Etidronic acid—Muscle spasms—Docetaxel—melanoma	0.00163	0.00476	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—CUBN—melanoma	0.00163	0.00311	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—SLC5A5—melanoma	0.00159	0.00304	CbGpPWpGaD
Etidronic acid—Hypersensitivity—Carmustine—melanoma	0.00158	0.00464	CcSEcCtD
Etidronic acid—Diarrhoea—Dactinomycin—melanoma	0.00157	0.0046	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—CSPG4—melanoma	0.00157	0.003	CbGpPWpGaD
Etidronic acid—Vomiting—Bleomycin—melanoma	0.00157	0.00458	CcSEcCtD
Etidronic acid—Anaemia—Docetaxel—melanoma	0.00156	0.00458	CcSEcCtD
Etidronic acid—Rash—Bleomycin—melanoma	0.00155	0.00455	CcSEcCtD
Etidronic acid—Dermatitis—Bleomycin—melanoma	0.00155	0.00454	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—RPS3—melanoma	0.00154	0.00295	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—PIK3CA—melanoma	0.00153	0.00293	CbGpPWpGaD
Etidronic acid—Hypersensitivity—Temozolomide—melanoma	0.00153	0.00448	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—SKI—melanoma	0.00152	0.00291	CbGpPWpGaD
Etidronic acid—Leukopenia—Docetaxel—melanoma	0.00151	0.00444	CcSEcCtD
Etidronic acid—Diarrhoea—Carmustine—melanoma	0.00147	0.00431	CcSEcCtD
Etidronic acid—Pruritus—Temozolomide—melanoma	0.00147	0.0043	CcSEcCtD
Etidronic acid—Nausea—Bleomycin—melanoma	0.00146	0.00428	CcSEcCtD
Etidronic acid—Vomiting—Dactinomycin—melanoma	0.00146	0.00428	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—CXCL1—melanoma	0.00145	0.00277	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PLCB4—melanoma	0.00145	0.00277	CbGpPWpGaD
Etidronic acid—Rash—Dactinomycin—melanoma	0.00145	0.00424	CcSEcCtD
Etidronic acid—Arthralgia—Docetaxel—melanoma	0.00144	0.00422	CcSEcCtD
Etidronic acid—Diarrhoea—Temozolomide—melanoma	0.00142	0.00416	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—HRAS—melanoma	0.00142	0.00271	CbGpPWpGaD
Etidronic acid—Confusional state—Docetaxel—melanoma	0.00139	0.00408	CcSEcCtD
Etidronic acid—Infection—Docetaxel—melanoma	0.00137	0.00402	CcSEcCtD
Etidronic acid—Vomiting—Carmustine—melanoma	0.00137	0.004	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—CUL3—melanoma	0.00136	0.00261	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—TRRAP—melanoma	0.00136	0.00261	CbGpPWpGaD
Etidronic acid—Nausea—Dactinomycin—melanoma	0.00136	0.00399	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—IL6—melanoma	0.00136	0.0026	CbGpPWpGaD
Etidronic acid—Rash—Carmustine—melanoma	0.00136	0.00397	CcSEcCtD
Etidronic acid—Dermatitis—Carmustine—melanoma	0.00135	0.00396	CcSEcCtD
Etidronic acid—Headache—Carmustine—melanoma	0.00135	0.00394	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—AKR1B10—melanoma	0.00133	0.00254	CbGpPWpGaD
Etidronic acid—Vomiting—Temozolomide—melanoma	0.00132	0.00387	CcSEcCtD
Etidronic acid—Rash—Temozolomide—melanoma	0.00131	0.00383	CcSEcCtD
Etidronic acid—Dermatitis—Temozolomide—melanoma	0.00131	0.00383	CcSEcCtD
Etidronic acid—Headache—Temozolomide—melanoma	0.0013	0.00381	CcSEcCtD
Etidronic acid—Nausea—Carmustine—melanoma	0.00128	0.00374	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Docetaxel—melanoma	0.00126	0.00368	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—HDAC6—melanoma	0.00126	0.0024	CbGpPWpGaD
Etidronic acid—Paraesthesia—Docetaxel—melanoma	0.00124	0.00363	CcSEcCtD
Etidronic acid—Nausea—Temozolomide—melanoma	0.00123	0.00361	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—F2RL1—melanoma	0.00123	0.00236	CbGpPWpGaD
Etidronic acid—Dyspepsia—Docetaxel—melanoma	0.00122	0.00356	CcSEcCtD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—ABCB1—melanoma	0.00121	0.00232	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—NPPA—melanoma	0.00119	0.00227	CbGpPWpGaD
Etidronic acid—Constipation—Docetaxel—melanoma	0.00118	0.00346	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—VCAN—melanoma	0.00116	0.00222	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—GRM3—melanoma	0.00116	0.00222	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—WNT5A—melanoma	0.00115	0.0022	CbGpPWpGaD
Etidronic acid—Feeling abnormal—Docetaxel—melanoma	0.00114	0.00333	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Docetaxel—melanoma	0.00113	0.00331	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—KISS1—melanoma	0.0011	0.0021	CbGpPWpGaD
Etidronic acid—Abdominal pain—Docetaxel—melanoma	0.00109	0.0032	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—SKI—melanoma	0.00106	0.00203	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CXCR1—melanoma	0.00106	0.00203	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MC1R—melanoma	0.00105	0.002	CbGpPWpGaD
Etidronic acid—Hypersensitivity—Docetaxel—melanoma	0.00102	0.00298	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—CCR7—melanoma	0.00101	0.00192	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—GRM1—melanoma	0.00101	0.00192	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—SUFU—melanoma	0.00098	0.00187	CbGpPWpGaD
Etidronic acid—Pruritus—Docetaxel—melanoma	0.000977	0.00286	CcSEcCtD
Etidronic acid—Diarrhoea—Docetaxel—melanoma	0.000945	0.00277	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—GAB2—melanoma	0.000925	0.00177	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—RHOB—melanoma	0.000915	0.00175	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—BCL2L11—melanoma	0.000915	0.00175	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—FASN—melanoma	0.000906	0.00173	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—HDAC6—melanoma	0.000879	0.00168	CbGpPWpGaD
Etidronic acid—Vomiting—Docetaxel—melanoma	0.000878	0.00257	CcSEcCtD
Etidronic acid—Rash—Docetaxel—melanoma	0.000871	0.00255	CcSEcCtD
Etidronic acid—Dermatitis—Docetaxel—melanoma	0.00087	0.00255	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—CXCR4—melanoma	0.00087	0.00166	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—HDAC2—melanoma	0.00087	0.00166	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—FOXO4—melanoma	0.00087	0.00166	CbGpPWpGaD
Etidronic acid—Headache—Docetaxel—melanoma	0.000865	0.00253	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—CD44—melanoma	0.00086	0.00164	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CXCR2—melanoma	0.000833	0.00159	CbGpPWpGaD
Etidronic acid—Nausea—Docetaxel—melanoma	0.00082	0.0024	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—RAC2—melanoma	0.00082	0.00157	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—WNT5A—melanoma	0.000807	0.00154	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—VEGFC—melanoma	0.000807	0.00154	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—AKT3—melanoma	0.000794	0.00152	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—ALB—melanoma	0.00076	0.00145	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—F2R—melanoma	0.000709	0.00135	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—ERBB4—melanoma	0.000701	0.00134	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CDKN2B—melanoma	0.000695	0.00133	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—EDNRB—melanoma	0.000686	0.00131	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CD86—melanoma	0.000672	0.00128	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PTK2B—melanoma	0.000666	0.00127	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—FGF1—melanoma	0.000652	0.00125	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—GAB2—melanoma	0.000648	0.00124	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—GNA11—melanoma	0.000648	0.00124	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—FLT1—melanoma	0.000645	0.00123	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PDGFRA—melanoma	0.000631	0.00121	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PRKCA—melanoma	0.000625	0.00119	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—ERCC2—melanoma	0.00062	0.00118	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—MAP2K2—melanoma	0.000611	0.00117	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CXCR4—melanoma	0.000609	0.00116	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—FOXO4—melanoma	0.000609	0.00116	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—HDAC2—melanoma	0.000609	0.00116	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—GNAQ—melanoma	0.000602	0.00115	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—TERT—melanoma	0.000581	0.00111	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—HLA-A—melanoma	0.000581	0.00111	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—RAC1—melanoma	0.00058	0.00111	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—SYK—melanoma	0.000566	0.00108	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—ITGAV—melanoma	0.000556	0.00106	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—AKT3—melanoma	0.000556	0.00106	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—NGFR—melanoma	0.000556	0.00106	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—HIF1A—melanoma	0.000556	0.00106	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—SOCS1—melanoma	0.000515	0.000984	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—S100B—melanoma	0.000514	0.000981	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—NOS2—melanoma	0.000506	0.000966	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—NOTCH1—melanoma	0.000501	0.000957	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—ERBB4—melanoma	0.000491	0.000939	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CD80—melanoma	0.000491	0.000937	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—APC—melanoma	0.00049	0.000936	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—KIT—melanoma	0.00049	0.000936	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CDKN2B—melanoma	0.000487	0.00093	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—EGF—melanoma	0.000484	0.000925	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CD86—melanoma	0.000471	0.0009	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—EDN1—melanoma	0.000467	0.000893	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—BRAF—melanoma	0.00046	0.000879	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—FGF1—melanoma	0.000457	0.000873	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CSF2—melanoma	0.000457	0.000873	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—E2F1—melanoma	0.000447	0.000854	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PDGFRA—melanoma	0.000442	0.000845	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PRKCA—melanoma	0.000438	0.000836	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—ITGB3—melanoma	0.000438	0.000836	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—MAP2K1—melanoma	0.000433	0.000828	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PIK3CD—melanoma	0.00043	0.000823	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—SPP1—melanoma	0.000429	0.00082	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MAP2K2—melanoma	0.000428	0.000818	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—FGF2—melanoma	0.000412	0.000788	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—TERT—melanoma	0.000407	0.000778	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—RAC1—melanoma	0.000406	0.000776	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—HIF1A—melanoma	0.000389	0.000744	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—MDM2—melanoma	0.000386	0.000737	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—ERBB2—melanoma	0.00038	0.000726	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PIK3CB—melanoma	0.000375	0.000717	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CD4—melanoma	0.000374	0.000716	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—KDR—melanoma	0.000372	0.000711	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PTGS2—melanoma	0.000372	0.00071	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—FN1—melanoma	0.000358	0.000685	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CDKN1B—melanoma	0.000352	0.000673	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—NOTCH1—melanoma	0.000351	0.00067	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CD80—melanoma	0.000343	0.000656	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PIK3CG—melanoma	0.000343	0.000655	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—APC—melanoma	0.000343	0.000655	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—KIT—melanoma	0.000343	0.000655	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—EGF—melanoma	0.000339	0.000648	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CTNNB1—melanoma	0.000333	0.000636	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CDKN1A—melanoma	0.000325	0.000621	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PTEN—melanoma	0.000324	0.00062	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—BRAF—melanoma	0.000322	0.000616	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—IGF1—melanoma	0.000314	0.0006	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MAP2K1—melanoma	0.000303	0.00058	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PIK3CD—melanoma	0.000301	0.000576	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—STAT3—melanoma	0.00029	0.000554	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—NRAS—melanoma	0.000289	0.000553	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—FGF2—melanoma	0.000289	0.000552	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—MAPK3—melanoma	0.000277	0.000529	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MDM2—melanoma	0.00027	0.000516	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—MYC—melanoma	0.000269	0.000515	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—ERBB2—melanoma	0.000266	0.000509	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—MAPK1—melanoma	0.000264	0.000504	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—EGFR—melanoma	0.000264	0.000504	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PIK3CB—melanoma	0.000263	0.000502	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CXCL8—melanoma	0.000252	0.000482	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—KRAS—melanoma	0.000249	0.000476	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CDKN1B—melanoma	0.000247	0.000471	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CASP3—melanoma	0.000242	0.000462	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—IL2—melanoma	0.000241	0.000461	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CCND1—melanoma	0.000235	0.000449	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CTNNB1—melanoma	0.000233	0.000445	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PIK3CA—melanoma	0.000229	0.000437	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MMP9—melanoma	0.000228	0.000436	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CDKN1A—melanoma	0.000228	0.000435	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PTEN—melanoma	0.000227	0.000434	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—NFKB1—melanoma	0.000226	0.000432	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—HRAS—melanoma	0.000212	0.000404	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—VEGFA—melanoma	0.000205	0.000392	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—STAT3—melanoma	0.000203	0.000388	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—NRAS—melanoma	0.000203	0.000387	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—IL6—melanoma	0.000203	0.000387	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MAPK3—melanoma	0.000194	0.000371	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MYC—melanoma	0.000189	0.000361	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—AKT1—melanoma	0.000187	0.000357	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MAPK1—melanoma	0.000185	0.000353	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—EGFR—melanoma	0.000185	0.000353	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—KRAS—melanoma	0.000174	0.000333	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PIK3CA—melanoma	0.00016	0.000306	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—TP53—melanoma	0.000155	0.000296	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—HRAS—melanoma	0.000148	0.000283	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—IL6—melanoma	0.000142	0.000271	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—AKT1—melanoma	0.000131	0.00025	CbGpPWpGaD
